Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Current Leases (2019 - 2025)

OptimizeRx's Current Leases history spans 7 years, with the latest figure at $207000.0 for Q3 2025.

  • For Q3 2025, Current Leases rose 6.15% year-over-year to $207000.0; the TTM value through Sep 2025 reached $207000.0, up 6.15%, while the annual FY2024 figure was $168000.0, 24.32% down from the prior year.
  • Current Leases for Q3 2025 was $207000.0 at OptimizeRx, down from $209000.0 in the prior quarter.
  • Across five years, Current Leases topped out at $233000.0 in Q1 2024 and bottomed at $14545.0 in Q2 2023.
  • The 5-year median for Current Leases is $110271.0 (2021), against an average of $131464.6.
  • The largest annual shift saw Current Leases tumbled 83.41% in 2023 before it surged 1405.67% in 2024.
  • A 5-year view of Current Leases shows it stood at $90982.0 in 2021, then fell by 1.19% to $89902.0 in 2022, then surged by 146.94% to $222000.0 in 2023, then fell by 24.32% to $168000.0 in 2024, then grew by 23.21% to $207000.0 in 2025.
  • Per Business Quant, the three most recent readings for OPRX's Current Leases are $207000.0 (Q3 2025), $209000.0 (Q2 2025), and $139000.0 (Q1 2025).